Ongoing Data Collection | June 2022

Assessment of Birth Outcomes in Eswatini after Transition to Dolutegravir-based Treatment

Overview

Country:

Eswatini

Subject Matter:

Maternal, Newborn, and Child Health; Pediatric and Adolescent Testing, Care, and Treatment

The aim of this ViiV-funded observational study is to evaluate the birth outcomes of HIV-positive women who are receiving Dolutegravir or other ARV drug regimens in Eswatini.

Data Collection Period: 09/2021 – 09/2022

Explore Other Research

In Analysis Birth Surveillance in Eswatini Following Transition To Dolutegravir-based Treatment Maternal, Newborn, and Child Health; PMTCT and HIV-free Survival
In Analysis Assessing the Effectiveness of Integration of Rapid Antigen Testing for SARS-CoV-2 in MNCH, HIV and TB Services in Cameroon and Kenya: A Pre- and Post- Implementation Evaluation (Effectiveness Integration) Adult Testing, Care, and Treatment; COVID-19; Pediatric and Adolescent Testing, Care, and Treatment
In Analysis Evaluation of the Differentiated Care Model for Advanced HIV Disease in Côte d’Ivoire DICACI study Adult Testing, Care, and Treatment; Pediatric and Adolescent Testing, Care, and Treatment
All Research